Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Frumovitz

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|June 23, 2014
Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancerNadeem Abu-Rustum, Dennis Chi, Robert L Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Journal of Pain and Symptom Management|December 21, 2020
An Integrated Approach to Selecting a Prepared Medical Decision-MakerDonna S Zhukovsky, Ali Haider, Janet L Williams, et al.
American Journal of Obstetrics and Gynecology|January 8, 2024
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumorsJeffrey A How, Alejandra Flores Legarreta, Katelyn F Handley, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
Head & Neck|May 17, 2020
Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisisJudy Overton, Kathy Denton, Michael Frumovitz, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 3, 2020
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancersNadeem R Abu-Rustum, Roberto Angioli, Arthur E Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|June 23, 2014
Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancerNadeem Abu-Rustum, Dennis Chi, Robert L Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Journal of Pain and Symptom Management|December 21, 2020
An Integrated Approach to Selecting a Prepared Medical Decision-MakerDonna S Zhukovsky, Ali Haider, Janet L Williams, et al.
American Journal of Obstetrics and Gynecology|January 8, 2024
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumorsJeffrey A How, Alejandra Flores Legarreta, Katelyn F Handley, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
Head & Neck|May 17, 2020
Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisisJudy Overton, Kathy Denton, Michael Frumovitz, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 3, 2020
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancersNadeem R Abu-Rustum, Roberto Angioli, Arthur E Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Pageof 23